SARS-CoV-2 infection enhancement by Amphotericin B: Implications for disease management
Dung V. Nguyen, Stephen M. Laidlaw, Xiaofeng Dong, Matthew E. Wand, Amanda Horton, Mark Sutton, Julia A. Tree, Rachel Milligan, Maximilian Erdmann, David A. Matthews, Andrew D. Davidson, Khondaker Miraz Rahman, Julian A. Hiscox, Miles W. Carroll
This study shows Amphotericin B and Nystatin enhance SARS-CoV-2 replication in vitro by promoting viral entry, suggesting they should not be used in active COVID-19 cases.
Journal of Virology · Jun 4, 2025Peer-reviewedMicrobiology